NEW YORK, Aug. 20, 2013 /PRNewswire-iReach/ -- Within weeks of the Supreme Court's historic decision declaring that human genes cannot be patented, two scientists have started a company that will democratize the human genome and give people direct access to their own genetic information – which can have an immediate impact on their health and well being. The court's decision spurred the two scientists, Christopher Mason, PhD, of Weill Cornell Medical College, and Jeffrey Rosenfeld, PhD, of Rutgers Medical School, to form Genome Liberty and begin offering immediate, personalized genetic testing directly to the public – although the results should used in concert with a doctor.
"The Supreme Court's decision opened an era of genomic liberty, allowing people to look at the DNA for all of their genes – which had been hidden behind patent walls for companies that had a monopoly on such testing," Mason said. "Our next-generation sequencing technology allows individuals to be proactive in understanding how their genome can affect their health decisions."
Previously, individuals had to rely on their doctors to understand their health and to make proper medical decisions for them. As scientists and doctors have found the molecular basis for disease and drug response, it has become increasingly clear that a "one-size-fits-all" framework for medicine is not in patients' best interest.
"Genome Liberty fills an important void in our current medical system," Rosenfeld said. "For example, there are clear genetic markers for many medications that will determine whether a person will respond properly or may have extreme side-effects, including estrogen, codeine, Plavix, Nexium, Prilosec, Zocor, Dilantin, Coumadin, Hal
|SOURCE Genome Liberty|
Copyright©2012 PR Newswire.
All rights reserved